Stockscreener 앱 받기
11.64
2.19%
0.25
전일 마감가:
$11.39
열려 있는:
$11.46
하루 거래량:
2.47M
Relative Volume:
0.78
시가총액:
$1.60B
수익:
$4.25B
순이익/손실:
$-1.40B
주가수익비율:
-1.1326
EPS:
-10.2775
순현금흐름:
$143.60M
1주 성능:
+1.13%
1개월 성능:
+7.28%
6개월 성능:
-22.91%
1년 성능:
-53.88%
1일 변동 폭
$11.31
$11.66
1주일 범위
$11.26
$12.01
52주 변동 폭
$9.225
$28.43
페리고 Stock (PRGO) Company Profile
명칭
Perrigo Company Plc
전화
269-673-8451
주소
THE SHARP BUILDING, DUBLIN 2
Compare PRGO vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRGO
Perrigo Company Plc
|
11.64 | 1.60B | 4.25B | -1.40B | 143.60M | -10.28 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.28B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.33B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.76B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 40.70B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.28B | 3.18B | 1.33B | 1.04B | 27.90 |
페리고 Stock (PRGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-01-14 | 다운그레이드 | Argus | Buy → Hold |
| 2025-01-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-09-24 | 재개 | Jefferies | Hold |
| 2023-11-17 | 개시 | Piper Sandler | Overweight |
| 2023-03-07 | 개시 | Canaccord Genuity | Buy |
| 2022-09-14 | 업그레이드 | Argus | Hold → Buy |
| 2022-09-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-09-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-01-06 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-04-17 | 다운그레이드 | Argus | Buy → Hold |
| 2020-03-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-20 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-18 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-10-11 | 업그레이드 | Argus | Hold → Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2018-11-13 | 다운그레이드 | Berenberg | Buy → Hold |
| 2018-08-10 | 재확인 | Stifel | Hold |
| 2018-07-30 | 다운그레이드 | Argus | Buy → Hold |
| 2018-07-12 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-01-03 | 개시 | Leerink Partners | Mkt Perform |
| 2017-12-08 | 업그레이드 | Argus | Hold → Buy |
| 2017-11-10 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2017-10-05 | 재확인 | UBS | Buy |
| 2017-09-07 | 개시 | Oppenheimer | Outperform |
| 2017-08-11 | 업그레이드 | Goldman | Sell → Neutral |
| 2017-08-11 | 재확인 | RBC Capital Mkts | Underperform |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-06-05 | 다운그레이드 | RBC Capital Mkts | Sector Perform → Underperform |
| 2017-03-03 | 재확인 | B. Riley & Co. | Neutral |
모두보기
페리고 주식(PRGO)의 최신 뉴스
How Investors Are Reacting To Perrigo (PRGO) Dermacosmetics Sale, Dividend Payout, And Infant Formula Strains - Yahoo Finance
Perrigo Shareholders Endorse Directors, Pay and Capital Flexibility - TipRanks
Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
Perrigo (PRGO) investors back 2026 incentive plan and elect board - Stock Titan
Perrigo earnings ahead: Can cost savings counter portfolio reset? By Investing.com - Investing.com India
Perrigo earnings ahead: Can cost savings counter portfolio reset? - Investing.com
MSN Money - MSN
Perrigo Co. PLC stock underperforms Monday when compared to competitors - MarketWatch
Perrigo Company (PRGO) Q1 2026 Preview: EPS Est. $0.31, Reports May 6 - AlphaStreet
Rizwan Mir | ChicagoCISO ORBIE® Awards - Crain's Chicago Business
Perrigo Company plc (NYSE: PRGO) Long Term Investor Alert: Investigation of potential Wrongdoing - openPR.com
Perrigo Dermacosmetics Sale Tests Focused Self Care And Debt Reduction - Sahm
Short Interest in Perrigo Company plc (NYSE:PRGO) Drops By 16.6% - MarketBeat
Perrigo completes sale of dermacosmetics unit for €332.6m By Investing.com - Investing.com India
Perrigo completes sale of dermacosmetics unit for €332.6m - Investing.com UK
Perrigo Completes Divestiture of Dermacosmetics Business - Barchart.com
FDA says U.S. baby formula supplies are safe (ABT:NYSE) - Seeking Alpha
Perrigo Q2 2025 Earnings Preview - MSN
Understanding the Setup: (PRGO) and Scalable Risk - Stock Traders Daily
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Perrigo Company plc Announces Quarterly Dividend of $0.29 (NYSE:PRGO) - MarketBeat
Perrigo Announces Quarterly Dividend - StreetInsider
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Perrigo declares $0.29 quarterly dividend, payable June 16 By Investing.com - Investing.com South Africa
Perrigo declares $0.29 quarterly dividend, payable June 16 - Investing.com
Press Release: Perrigo Announces Quarterly Dividend - Moomoo
Zacks Research Forecasts Perrigo's Q2 Earnings (NYSE:PRGO) - MarketBeat
Perrigo (NYSE:PRGO) Stock Rating Upgraded by Zacks Research - MarketBeat
Perrigo (PRGO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Perrigo to Buy Elan for $8.6 Billion - AOL.com
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now - AOL.com
3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now - The Motley Fool
Perrigo Company plc announces Quarterly dividend, payable on June 16, 2026 - marketscreener.com
Vanguard Portfolio Management (PRGO) owns 8.25M shares, 5.99% stake - Stock Titan
[SCHEDULE 13G] PERRIGO Co plc Passive Investment Disclosure (>5%) - Stock Titan
Perrigo: Positioning Through A Thesis Reset (PRGO) - Seeking Alpha
Is Perrigo (PRGO) Offering Value After A 49.9% One Year Share Price Decline? - Yahoo Finance
Perrigo gains amid takeover speculation - MSN
Perrigo Co. PLC stock underperforms Thursday when compared to competitors - MarketWatch
Why Did Perrigo Stock Tumble 9% Pre-Market Today? - MSN
Perrigo to Release First Quarter 2026 Financial Results on May 6 - GuruFocus
Perrigo Updates Segment Reporting and Profitability Metrics - TipRanks
Perrigo updates financial reporting segments to reflect product categories By Investing.com - Investing.com South Africa
Perrigo updates financial reporting segments to reflect product categories - Investing.com
Perrigo (PRGO) recasts segments and records $1.3B goodwill impairment in 2025 - Stock Titan
Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026 - Caledonian Record
페리고 (PRGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):